SCHEMBL4585773

SCHEMBL4585773

O=C1C=COSN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699281 0.59
SCHEMBL8402436 0.59
SCHEMBL1077045 0.56
SCHEMBL5894785 0.56
SCHEMBL28390358 0.56
SCHEMBL3114602 0.51
SCHEMBL616019 0.50
SCHEMBL10990 0.50
SCHEMBL693917 0.50 GSK3B (1.00)
SCHEMBL369085 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618780-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 EP claimed
EP-4618781-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2025-09-24 EP claimed
WO-2024105407-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2024-05-23 WO claimed
WO-2024105406-A1 CONSUMABLE FOR AEROSOLISABLE FORMULATION Nicoventures Trading Limited (GB) 2024-05-23 WO claimed
WO-2007076413-A2 ANTIMICROBIAL DURABLE MEDICAL EQUIPMENT MICROBAN PRODUCTS COMPANY (US) 2007-07-05 WO claimed
EP-1790334-A2 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach Depomed, Inc. (US) 2007-05-30 EP claimed
EP-1136487-B1 Nicotine salts with improved taste, process for their preparation and use thereof as smoking cessation agents NUTRINOVANUTRITION SPECIALTIES (DE) 2005-05-25 EP claimed
US-20040173224-A1 Nicotine salts having improved taste, process for their preparation and their use BURGARD ANDREAS (DE) 2004-09-09 US claimed
WO-2003077846-A2 NEW THERAPEUTIC METHOD OF DELIVERING A MEDICAMENT TO AVOID IRRITATING EFFECTS ON MEMBRANES OF USER CAPLAN JAY L (US) 2003-09-25 WO claimed
US-20030171408-A1 Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user CAPLAN JAY L (US) 2003-09-11 US claimed
EP-1135239-A1 WOOD PRESERVATIVE FORMULATIONS HICKSON INTERNATIONAL PLC (GB) 2001-09-26 EP claimed
WO-2000032371-A1 WOOD PRESERVATIVE FORMULATIONS HICKSON INTERNATIONAL PLC (GB) 2000-06-08 WO claimed
US-4876085-A GREASY HAIR, SKIN L'OREAL (FR) 1989-10-24 US claimed
EP-0134895-B1 PROCESS AND COMPOUNDS FOR APPLYING ACCELERATED AND GRAIN-REFINED PHOSPHATE COATINGS TO METALLIC SURFACES Gerhard Collardin GmbH (DE) 1988-11-30 EP claimed
US-4680064-A Phosphate conversion coating accelerators GERHARD COLLARDIN GMBH (DE) 1987-07-14 US claimed
US-4132772-A Dentifrice COLGATE PALMOLIVE COMPANY (US) 1979-01-02 US claimed
US-3969348-A Process for the manufacture of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-13 US claimed
US-3968107-A Process for the manufacture of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-06 US claimed
US-3968106-A Process for the manufacture of 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide and its use as sweetener HOECHST AKTIENGESELLSCHAFT (DT) 1976-07-06 US claimed
US-3932606-A SWEETENERS, 3,4-DIHYDRO-1,2,3-OXATHIAZIN-4- ONE COLGATE-PALMOLIVE COMPANY (US) 1976-01-13 US claimed